eltrombopag 12.5 MG Powder for Oral Suspension [Promacta]

RxCUI: 2058981
RxNorm name: eltrombopag 12.5 MG Powder for Oral Suspension [Promacta]
Display name: eltrombopag 12.5 MG Powder for Oral Suspension [Promacta]
Full name: eltrombopag 12.5 MG Powder for Oral Suspension [Promacta]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
PROMACTA	ELTROMBOPAG OLAMINE	Novartis Pharmaceuticals Corporation	7714a0ed-34bb-46e6-a0a5-b363908b22c2	2025-12-18	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2058981

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
7714a0ed-34bb-46e6-a0a5-b363908b22c2	eltrombopag 12.5 MG Powder for Oral Suspension [Promacta]	SBD	31	These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA ® (eltrombopag) tablets, for oral use PROMACTA ® (eltrombopag) for oral suspension Initial U.S. Approval: 2008	20251218
7714a0ed-34bb-46e6-a0a5-b363908b22c2	Promacta (as eltrombopag olamine) 12.5 MG Powder for Oral Suspension	SY	31	These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA ® (eltrombopag) tablets, for oral use PROMACTA ® (eltrombopag) for oral suspension Initial U.S. Approval: 2008	20251218
7714a0ed-34bb-46e6-a0a5-b363908b22c2	Promacta 12.5 MG Powder for Oral Suspension	PSN	31	These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA ® (eltrombopag) tablets, for oral use PROMACTA ® (eltrombopag) for oral suspension Initial U.S. Approval: 2008	20251218